Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 61 - 80 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Dec 2009, 10:16 pm
Supporters can click the Make it Happen link and send an email to the CEOs of Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer Inc. and Sequoia Pharmaceuticals Inc. [read post]
29 Dec 2009, 9:09 pm by ipdeals
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
9 Mar 2015, 2:38 pm by The Public Employment Law Press
Litigation and Government Investigations at Boehringer Ingelheim Pharmaceuticals where she oversaw all U.S. litigation and government investigations. [read post]
26 Oct 2012, 12:53 pm by Joe Consumer
s announcement of another big health care fraud settlement, specifically, Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted.… Thursday's announcement is the latest in a series of settlements with pharmaceutical companies engaging in so-called off-label marketing. [read post]
26 Apr 2007, 9:28 am
The two big trade mark decisions of the European Court of Justice today have been a little overshadowed by the festivities for World Intellectual Property Day, but the IPKat took just enough time off from his ecstatic celebrations to check the Curia website and see what the ECJ had in store for him.Right: objection to the repackaging of pharma products has led to some grey goods traders taking extreme measures to avoid trade mark infringment litigationCase C-348/04, Boehringer… [read post]
9 Nov 2020, 3:00 am by Brian
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am by Brian
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
9 Nov 2020, 3:00 am by Brian
Currently, the defendants in active Zantac cancer injury cases include: Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
1 Aug 2019, 8:30 am by Seeger Weiss LLP
Boehringer Ingelheim Corp., et al., a $150 million settlement with GlaxoSmithKline PLC, and a $190 million settlement with Aventis Pharmaceuticals, Inc. [read post]
6 Nov 2007, 5:55 am
Rosenbaum, District of MinnesotaNature of Suits: Consists of 58 actions against Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc. arising from use of Mirapex, a treatment for Parkinson's disease, which alleged causes obsessive pleasure- and reward-seeking behavior, such as gambling.In re Kugel Mesh Hernia Patch Products Liability Litigation, MDL 1842Filed 2/28/07 and ordered to be transferred on 6/22/2007Transferee Judge and Court: Mary H. [read post]
15 Jun 2012, 2:51 pm by bradhendrickslawfirm
Pradaxa Approved by FDA in 2010 and Investigated by 2011 In 2010, the United States Food & Drug Administration (FDA) approved Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., as a direct thrombin inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. [read post]
12 Jan 2012, 4:21 am
The IPKat has always been unhappy at the bit in Case C-348/04 Boehringer Ingelheim KG v Swingward Ltd: where the Court of Justice of the European Union said: "Where a parallel importer has failed to give prior notice to the trade mark proprietor concerning a repackaged pharmaceutical product, he infringes that proprietor’s rights on the occasion of any subsequent importation of that product, so long as he has not given the proprietor such notice. [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
9 Nov 2012, 2:15 pm by Tom Lamb
November 7, 2012:  "Interim Results from RELY-ABLE®, the RE-LY® Extension Study, Provide Additional Clinical Evidence for the Safety of Pradaxa® (dabigatran etexilate mesylate)"  (Drug company Press Release) @EXCERPT:  Boehringer Ingelheim Pharmaceuticals, Inc. today announced interim results from the RELY-ABLE® trial, a long-term extension of the RE-LY® study. [read post]
8 Jul 2015, 8:31 am by Katharyn Grant (US)
Labs., Inc., 625 F.2d 1055 (3d Cir. 1980) (holding unique coloring of prescription drug capsule constituted protectable trade dress); Boehringer Ingelheim G.m.b.H. v. [read post]
5 Jun 2014, 7:06 am by Daniel Schwartz
 Boehringer Ingelheim Pharmaceuticals, Inc., which was decided just a few months before I started my career in employment law. [read post]